2021, www.nejm.org/doi/full/10.1056/NEJMoa2032183 ++ Garvey, W
Similarly, obesity management requires evidence-based approaches
Explore the TRIUMPH-Outcomes trial
The second part of this is the fact that within the first couple of days, youre looking at almost half the people are going to get some kind of gastrointestinal side effects, nausea, vomiting, diarrhea, constipation
A small increase in resting heart rate does not necessarily mean retatrutide causes serious heart problems, but heart safety is still being monitored because the medicine is investigational
relevance to humans is currently unknown, and individuals with MTC or MEN2 history are excluded from trials